Product
KT-474
1 clinical trial
3 indications
Indication
Healthy VolunteerIndication
Atopic DermatitisIndication
Hidradenitis SuppurativaClinical trial
A Phase 1 Randomized, Placebo-controlled, Single and Multiple Ascending Dose Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orally Administered KT-474 in Healthy Adult Volunteers and Patients With Atopic Dermatitis (AD) or Hidradenitis Suppurativa (HS)Status: Completed, Estimated PCD: 2022-10-20